NEW YORK – In light of the COVID-19 pandemic, the UK's National Institute for Health and Care Excellence has issued a list of interim treatment options aimed at limiting the risk of infection for cancer patients in England.
NICE, NHS England's Pandemic Guideline Gives Temporary Access to Precision Oncology Treatments
Premium
Get the full story with
Premium Access
Only $95 for the
first 90 days*
Premium Access gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a Precision Oncology News or 360Dx or GenomeWeb Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.